September 19, 2018 by Chain Drug Review
Allied Against Opioid Abuse (AAOA), B. Douglas Hoey, Healthcare Distribution Alliance (HDA), John Gray, Marsha Millonig, National Alliance for State Pharmacy Associations (NASPA), National Community Pharmacists Association (NCPA), opiod epidemic
Leading Headlines, Pharmacy
ARLINGTON, Va. — Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines. AAOA, along with its founding member, the Healthcare Distribution Alliance (HDA),
August 23, 2018 by Chain Drug Review
B. Douglas Hoey, National Community Pharmacists Association, nne Cassity
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — National Community Pharmacists Association’s chief executive officer Douglas Hoey announced that Anne Cassity has joined NCPA as vice president, federal and state government affairs, as the organization continues to grow its advocacy influence. A seasoned government affairs professional, Cassity formerly managed NCPA’s federal advocacy program. She left NCPA in 2011 to become health care
July 13, 2018 by Chain Drug Review
B. Douglas Hoey, Medicare Part D, Morning Consult, National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Reducing drug costs borne by seniors due to middlemen and deals in the drug supply chain are Medicare Part D reforms that most strongly curry favor among registered voters, according to a Morning Consult survey commissioned by the National Community Pharmacists Association (NCPA). Conducted in late June, the survey results indicate strong support
March 19, 2018 by Chain Drug Review
B. Douglas Hoey, Cigna, Cigna-Express Scripts merger, CVS-Aetna merger, David Cordani, Express Scripts, Tim Wentworth
2018, Issue 03-19-2018, Issues, News
BLOOMFIELD, Conn. — Another blockbuster merger is adding momentum to the consolidation wave sweeping through the health care sector, and again crossing industry segments. Health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal. Under the agreement, unveiled earlier this month, Cigna will pay Express
March 16, 2018 by Chain Drug Review
American Pharmacists Association, B. Douglas Hoey, Claire McCaskill, CVS Health, Debbie Stabenow, Know the Lowest Price Act, National Community Pharmacists Association, Patient Right to Know Drug Prices Act, Pharmaceutical Care Management Association, pharmacy gag clauses, prescription drug pricing transparency, S. 2553, S. 2554, Susan Collins, Tom Menighan
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 9, 2018 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, independent pharmacy owners, Medicare Part D, National Community Pharmacists Association, NCPA, S. 413 / H.R. 1038
CDR Blog
Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at
February 2, 2018 by CDR Blog and Chain Drug Review
B. Douglas Hoey, community pharmacies, independent pharmacies, independent pharmacy owners, National Community Pharmacists Association, oseltamivir, Tamiflu
CDR Blog
Without a doubt, pharmacies of all stripes are being challenged in this busy flu season, as the number of cases nationwide continues to escalate. Just go to any drug store, and you’ll likely see a queue at the pharmacy counter and a steady flow of concerned-looking people entering and exiting the cold/cough medicine aisles. This
January 15, 2018 by Chain Drug Review
B. Douglas Hoey, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services, CMS-4182-P Medicare Program, community pharmacies, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA, PBM business model, pharmacy benefit managers
2018, Issue 01-15-2018, Issues, Opinion
WASHINGTON — In recent testimony before the House of Representatives Energy and Commerce Subcommittee on Health, National Community Pharmacists Association (NCPA) chief executive officer B. Douglas Hoey said pharmacists can drive better health outcomes and reduce costs, but first pharmacy benefit managers’ problematic business practices must be addressed through legislative and regulatory channels. As an
January 10, 2018 by B. Douglas Hoey and Chain Drug Review
B. Douglas Hoey, Community Care of North Carolina, community pharmacists, community pharmacy, CPESN–USA, DIR fees, IDNs, independent pharmacies, integrated delivery networks, National Community Pharmacists Association, NCPA, pharmacy benefit manager business model, pharmacy DIR legislation, prescription drug abuse
Opinion
Community pharmacy owners occupy a critical position in the pharmacy marketplace and, even more importantly, as health care providers in communities across the country. Most stakeholders in the profession understand the vital marketplace check and balance that independent businesses provide. If only two or three megachain drug stores existed, negotiations with payers would look very
January 1, 2018 by Chain Drug Review
Affordable Care Act, B. Douglas Hoey, Bill Pascrell, federal tax overhaul, individual mandate, John Barrasso, John Cornyn, Jon Kingsdale, Lindsey Graham, Matthew Shay, Medicaid expansion, National Community Pharmacists Association, National Retail Federation, Obamacare, Sherrod Brown, tax reform legislation
2018, Issue 01-01-2018, Issues, Leading Headlines, News
WASHINGTON — The individual mandate is no more. The requirement under the Affordable Care Act that people pay a penalty if they do not obtain health insurance was eliminated in the federal tax overhaul passed by Congress. After the Senate approved the tax reform legislation 51-48, Trump tweeted, “Terrible Individual Mandate (ObamaCare) Repealed.” He signed
December 13, 2017 by Chain Drug Review
B. Douglas Hoey, DIR fees, Examining the Drug Supply Chain, Mark Merritt, National Community Pharmacists Association, NCPA, PBM industry, Pharmaceutical Care Management Association, pharmacy benefit manager, prescription drug costs, U.S. House of Representatives Energy & Commerce Committee, video
Videos
At a health subcommittee hearing of the U.S. House of Representatives Energy & Commerce Committee, B. Douglas Hoey, CEO of the National Community Pharmacists Association (NCPA), called for legislative and regulatory action on pharmacy benefit manager (PBM) business practices to help rein in prescription drug costs. The hearing, titled “Examining the Drug Supply Chain”
November 14, 2017 by Chain Drug Review
Alex Azar, ational Community Pharmacists Association, B. Douglas Hoey, Bernie Sanders, Eli Lilly, HHS secretary, Lamar Alexander, Lilly USA, President Donald Trump, secretary of the U.S. Department of Health and Human Services, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — Biopharmaceutical industry executive Alex Azar has been nominated as secretary of the U.S. Department of Health and Human Services (HHS) to fill the post vacated by Tom Price. Azar is currently founder and chairman of Seraphim Strategies LLC, an Indianapolis-based consultancy focused on the biopharma and health insurance industries, including biopharmaceutical sales, marketing, pricing,
November 6, 2017 by Jeffrey Woldt and Chain Drug Review
2017 NCPA Digest, B. Douglas Hoey, Community Pharmacy Enhanced Services Network, CPESN, independent drug stores, independent pharmacies, Jeffrey Woldt, National Community Pharmacists Association, NCPA
2017, Issue 11-06-2017, Issues, Opinion
More often than not, independent drug stores are overshadowed by the big retail chains. While it’s understandable why individual pharmacists who own one or two locations do not receive the same level of attention as the top pharmacy operators, the largest of which each have thousands of stores across the United States, in the aggregate